One of the more popular consumption options is to grind the cannabis bud and smoke it either in a device (like a pipe) or to use rolling papers to roll it into a marijuana cigarette (joint). If you wish to directly consume the cannabis bud but don’t wish to smoke, you can always use a Vaporizer – which is part of Beleave’s harm reduction program.
Press Releases
For news on what we’ve been up to, please click one of the following links:
BELEAVE RECEIVES APPROVAL FOR HAMILTON FACILITY EXPANSION FROM CITY COUNCIL
BELEAVE’S HAMILTON EXPANSION SET FOR CONSIDERATION BY PLANNING COMMITTEE ON MAY 14
BELEAVE ANNOUNCES INITIAL CANNABIS OIL SALES AFTER RECEIVING HEALTH CANADA AUTHORIZATION
BELEAVE GRANTED BUILDING PERMIT FOR UPCOMING LONDON EXPANSION
BELEAVE ANNOUNCES 256% INCREASE IN REVENUES IN THIRD QUARTER OF 2018 RESULTS
BELEAVE’S NEW BOARD MAKES KEY APPOINTMENTS TO STRENGTHEN INDEPENDENCE
BELEAVE ANNOUNCES BOARD AND MANAGEMENT REFRESH
MEDI-GREEN INVITES THE COMMUNITY TO GRAND OPENING OF ITS NEW CLINIC IN LONDON, ONTARIO
BELEAVE AWARDED ISO 9001:2015 CERTIFICATION AS PART OF ONGOING COMMITMENT TO IMPROVE EFFICIENCY
BELEAVE PROVIDES AN UPDATE ON THE BCSC’S TEMPORARY ORDER
BELEAVE ANNOUNCES EXECUTIVE MANAGEMENT DEVELOPMENTS AND PROVIDES ACTIVITY UPDATES
BELEAVE RECEIVES HEALTH CANADA AUTHORIZATION TO SELL CANNABIS OILS
BELEAVE ANNOUNCES GMP CERTIFICATION AND OPERATIONAL UPDATES
BELEAVE ANNOUNCES SECOND QUARTER OF 2018 RESULTS
BELEAVE ANNOUNCES RELEASE DATE OF SECOND QUARTER 2018 RESULTS AND CONFERENCE CALL
BELEAVE ANNOUNCES 90 NEW CANNABIS VARIETIES AS IT SECURES GENETICS ACQUISITION AGREEMENTS
BELEAVE ANNOUNCES SEVEN-FOR-ONE SHARE SPLIT
BELEAVE’S STATEMENT ON HISTORIC DAY FOR CANNABIS IN CANADA
BELEAVE ANNOUNCES 867,000 SQUARE FEET OF NEW INDOOR GROWING CAPACITY IN B.C.
BELEAVE SECURES PRIME LOCATION FOR ITS FIRST SASKATCHEWAN RETAIL STORE
BELEAVE RECEIVES FIRST PURCHASE ORDER FROM BC LIQUOR DISTRIBUTION BRANCH
BELEAVE RECEIVES PURCHASE ORDER FROM ONTARIO CANNABIS STORE
OCS SELECTS BELEAVE’S INITIAL LINE OF CANNABIS PRODUCTS FOR SALE IN ONTARIO
BELEAVE EXPANDS MEDI-GREEN NETWORK WITH THE ANNOUNCEMENT OF TWO NEW STORES
BELEAVE RAPIDLY ACCELERATES ITS RECREATIONAL DISTRIBUTION STRATEGY BY ACQUIRING SEVEN OAKS
BELEAVE APPLAUDS CANADIAN LEADERSHIP AND CONTINUED PROGRESS OF CANNABIS LEGALIZATION
BELEAVE EXPANDS ITS GLOBAL FOOTPRINT INTO COLOMBIA
BELEAVE INC. ANNOUNCES SUCCESSFUL SELECTION TO OPERATE A CANNABIS RETAIL STORE IN SASKATCHEWAN
BELEAVE LAUNCHES ROBUST SHAREHOLDER COMMUNICATIONS INITIATIVE
BELEAVE CLOSES ACQUISITION OF MEDI-GREEN CANNABIS CLINIC NETWORK
BELEAVE BEGINS EXTRACTION AT NEWLY COMMISSIONED STATE-OF-THE-ART INDUSTRIAL EXTRACTION LABORATORY
BELEAVE PROVIDES BASELINE MEDICAL CANNABIS YIELD PROJECTIONS
BELEAVE TO ACQUIRE MEDI-GREEN CANNABIS CLINIC NETWORK
BELEAVE CONFIRMS RECEIPT OF COMMITMENTS TO FULFILL $5,000,000 PRIVATE PLACEMENT
BELEAVE ANNOUNCES $5 MILLION NON-BROKERED PRIVATE PLACEMENT OF UNITS
BELEAVE RECEIVES SALES LICENSE FROM HEALTH CANADA
BELEAVE – EVERYTHING YOU’VE EVER WANTED TO KNOW
BELEAVE ANNOUNCES SIGNIFICANT APPOINTMENTS TO ITS BOARD
BELEAVE PROVIDES UPDATE ON MANITOBA RETAIL LICENSING AGREEMENT
BELEAVE RECEIVES NOTIFICATION OF PRE-SALE INSPECTION DATE
BELEAVE SIGNS LETTER OF INTENT WITH SEVEN OAKS CANNABIS
BELEAVE SIGNS BRAND LICENSING AGREEMENT WITH KEVIN SMITH AND JASON MEWES
BELEAVE RECEIVES LICENSE TO PRODUCE CANNABIS OILS FROM HEALTH CANADA
BELEAVE AIMS TO RAISE AWARENESS BY SUPPORTING DON’T DRIVE HIGH CAMPAIGN
BELEAVE ANNOUNCES UPSIZE OF PREVIOUSLY ANNOUNCED NON-BROKERED PRIVATE PLACEMENT
BELEAVE ANNOUNCES $5 MILLION NON-BROKERED PRIVATE PLACEMENTS OF UNITS
BELEAVE SUPPORTS RECENT COUNCIL DECISION AND CONTINUES EXPANSION UNINTERRUPTED
BELEAVE AND DR. MICHAEL ROGERS BEGIN RESEARCH IN CANNABIS FOOD AND DRUG DELIVERY
BELEAVE APPOINTS NEW CHEIF EXECUTIVE OFFICER ANDREW WNEK
BELEAVE COMPLETES FIRST HARVEST AT HAMILTON FACILITY
BELEAVE COMMENCES TRADING ON THE OTCQX MARKETS
DON’T DRIVE HI CAMPAIGN IS BUZZING — GOT A BAD CASE OF THE MUNCHIES? STAY OFF THE ROADS
BELEAVE BEGINS CULTIVATION AT HAMILTON FACILITY
BELEAVE REAFFIRMS “NO MATERIAL CHANGE”
BELEAVE PROVIDES CORPORATE UPDATE AND OUTLOOK AFTER RECEIVING LICENSE TO CULTIVATE CANNABIS
BELEAVE OBTAINS ACMPR LICENSE TO CULTIVATE MEDICAL CANNABIS
BELEAVE ANNOUNCES NON-DILUTIVE INTERIM STREAMING AGREEMENT WITH PANCANN
BELEAVE ANNOUNCES PRE-LICENSE INSPECTION DATE
Beleave and Ryerson University Continue Research and Development of Industrial Processes
Beleave Completes Facility Build Out and Upgrades in Advance of Future Expansion
Beleave and Ryerson Develop Unique Approach for Cannabinoid Extraction and Recovery
Beleave Announces Adoption of Advance Notice By-Law
Beleave Announces Debt Settlement
Beleave Announces Non-Brokered Private Placement for Gross Proceeds of $250,000
Beleave Provides Business Update
Beleave Closes Non-Brokered Private Placement for Gross Proceeds of $1,405,000
Beleave Announces Debt Settlement For Common Shares And Issuance of Options
Beleave Announces the Addition of Former Drug Prosecutor Chris Murphy to the Team
Beleave Announces Closing of Second Tranche of Private Placement
Beleave Strengthens Advisory Board with Addition of Andrew Steane
Beleave Completes Private Placement and Debt Settlement
BELEAVE RESEARCH PROJECT AWARDED GRANT FROM NSERC AND OPENS ONLINE STORE
Beleave Signs Memo of Understanding with Ryerson Uni Re Drug Standardization Research
Beleave Announces Debt Settlement for Common Shares and Services Transaction
Beleave Strengthens Board with Addition of Paul Evanov
Press Release Announcing Completion of Transaction
FASDF ASDFASDFASDFA
Mr. Kosalka has been trained and is experienced in materials, synthetic and analytical chemistry. While earning his Masters degree (MSc), he has had the privilege of presenting his work at various conferences including the 96th Canadian Chemistry Conference (Quebec City, Quebec, 2013) and the Chemistry and Biology Research Symposium at Ryerson University (Toronto, Ontario, 2013). He is experienced in laboratory management and teaching analytical chemistry at a University level. His interests lie in research which encompasses his three areas of expertise. Combining his research interests and his positive outlook on medical marihuana, he is always looking for new and interesting research opportunities in the field. His primary objective will be quality assurance. He will be responsible for evaluating products, ensuring that Health Canada requirements surrounding medical marijuana are not only met but exceeded and that all products are of the highest quality.
David Naranjit received his B.Sc. in Chemistry from McMaster University, Hamilton and his Ph. D. from the University of Toronto. His work has been in the field of analytical chemistry, particularly in atomic spectroscopy and chromatography. He has been a faculty member in the Department of Chemistry and Biology, Ryerson University since 1985, and has taught courses in the above stated areas. Based on David Naranjit’s extensive academic and research background and expertise in analytical chemistry applications and research, he provides expert counsel to the company regarding its ongoing research programs and standard practices. Particularly, these programs include, but are not limited to; the development of analytical techniques used to characterize cannabinoid products, advising on quality assurance practices and strategies and advising on the development of cannabis and cannabis delivery products. This role will specifically include providing general insights into the challenges and solutions in the field of medical cannabis and to provide feedback to management in the areas outlined above.
Mr. Gidlow is President of the Toronto Police Military Veterans Association, an organization formed in 1922, which is comprised of veterans of armed conflicts either with past service in Military Units, United Nations Peacekeeping Operations or service in Reserve Units with postings to areas of conflict such as Afghanistan. Mr. Gidlow served in the Canadian Forces Reserve Army from 1968 to 2011 when he retired as a Lieutenant Colonel after 43 years of service. In his time in the Canadian Forces, Mr. Gidlow did three tours, most recently to Afghanistan where he advised the Afghan National Police on site security. Dana will also play an important role in ensuring our facilities adhere to the highest in security standards. In addition to Mr. Gidlow’s service in the Canadian Forces, he served in the Toronto Police Service for 34 years and retired as a Supervisor in 2008. In this time, Mr. Gidlow worked on the Major Crime Unit, as a Criminal investigations Detective, and even as a Media Awareness Instructor. Mr. Gidlow was also deployed to Kosovo as an International Police Officer where among other roles, he investigated in theft and smuggling cases.
Mr. Panagiotakopoulos has spent ten (10) years in the Soil/Land Remediation industry as the Owner and CEO Cardinal Group’s Earth Works division – a company specializing in ground water remediation. In this capacity he has successfully devised and implemented numerous cost-effective bioremediation solutions that convert contaminants into harmless by-products and are environmentally safe in residential, commercial properties and salvage yards. Mr. Panagiotakopoulos has also spent five years as President and CEO of Hamilton Solar, where he successfully developed a 250 kW Solar Tracking generating plant for the Ontario Power Authority’s, Feed-In-Tariff program for renewable energy. He has built Ontario’s first large scale Elevated Solar Tracking farm on commercial land. Mr. Panagiotakopoulos joined Beleave two (2) years ago in capacity of director and COO. Mr. Panagiotakopoulos continues to use his resources as a seasoned veteran in managing construction projects to develop the project into becoming the most efficient and cost effective MMPR project. Upon completion of the Amalgamation, it is anticipated that Mr. Panagiotakopoulos will devote the time necessary to perform the work required in connection with acting as the COO and as a director of the Corporation.
Mr. Krasic has spent 5 years as an investment banker in Toronto. In this capacity, he began his career with Thomas Weisel Partners Canada Inc. and later joined Stifel Nicolaus Canada Inc. Mr. Krasic has experience in finance structuring, providing valuations, fairness opinions, exchange listings and various merger and acquisition transactions. His experience has enabled him to establish and service as CEO of Terrella Capital. He holds an honours degree from the University of Toronto in Finance and Economics, and a Masters Degree in Investment Management with a specialization in Capital Markets from Concordia University. Mr. Krasic joined FAM two (2) years ago in the capacity of a CFO and has helped develop various partnerships including legal, financial, and business development spectrums. He was instrumental in assisting FAM in raising capital and has played an integral role in developing FAM’s security and record keeping protocols.
A senior financial executive with significant retail, oil and gas and not for profit industry experience. Held senior finance roles with Canadian Tire Corporation including Senior Vice President, Finance and Administration in a twenty one year career. Also developed strong technology knowledge as the Chief Information Officer for over seven years for the Corporation. Most recently was the National CFO for the Heart and Stroke Foundation. Has served on several Boards including as Finance Chair for six years on the Royal Conservatory of Music Board and as Audit Committee Chair for Momentum, a technology service provider. Married with three children, has volunteered extensively for a number of schools and served with a community association for over ten years.
Mr. Chris Murphy is a Toronto-based regulatory and criminal lawyer. He sits on the board of directors of Star Produce Ltd., one of Canada’s largest distributors of fresh fruit and vegetables with more than 100 offshore programs and 200,000 square feet of refrigerated distribution space. Mr. Murphy will bring to Beleave a wealth of experience in logistics, food safety, greenhouse operations, and information systems capable of tracking product from seed to sale. Chris has broad experience and industry connections with greenhouses, distribution networks and retailers across North America, we welcome him on board as an invaluable asset that will assist in all areas of our business from production practices, expansion plans to sales. Mr. Murphy is a former drug prosecutor with the Department of Justice Canada. Before becoming a prosecutor, he acted as a judicial law clerk at the Supreme Court of British Columbia. Mr. Murphy also practiced civil litigation at a firm of some 150 lawyers in Calgary, Alberta. In addition, he served as a special constable with the Royal Canadian Mounted Police. Mr. Murphy received a Bachelor of Laws with Distinction in 2000. In 1997, he obtained a Master of Arts degree. He had previously graduated with a Bachelor of Arts Degree with High Honours in 1994. In 2004, he received a Certificate in International Criminal Law from Salzburg Law School, and in 2015 he graduated from the Directors Education Program at the University of Toronto’s Rotman School of Management.
Paul Evanov is a seasoned broadcasting executive with over 20 years experience in the radio and broadcasting industry. Mr. Evanov currently holds the title of Executive Vice President and Program Director at Evanov Radio Group, a company he was instrumental in building to Canada’s largest independent radio broadcaster. Mr. Evanov is currently responsible for the day-to-day operation of 18 radio stations across Canada with approximately 2.7 million weekly listeners. Mr. Evanov was inducted to the Humber College Radio Hall of Fame in 2014 just two years after his father was inducted into the Canadian Music and Broadcast Hall of Fame. Mr. Evanov will assist Beleave in its marketing and advertising initiatives.
Dr. Ferreira received his PhD training in the area of neuroimmunology, with a particular focus on the physiological mechanisms by which brain inflammation can be curbed, which is especially relevant to the neural harm that can occur with neurodegenerative disease, traumatic injury, and stroke. Roger has authored several peer-reviewed publications in the Journal of Neuroimmune Pharmacology, Frontiers in Cellular Neuroscience, Frontiers in Cellular Immunology, and the Public Library of Science; as well as having presented his work at several international conferences, including the Biophysical Society 56th Annual Meeting (San Diego, California, USA, 2012), the 7th Annual Canadian Neuroscience meeting (Toronto, Ontario, Canada, 2013), and the Biophysical Society 59th Annual Meeting (Baltimore, Maryland, USA, 2015). His area of research is particularly relevant to medical marihuana, as there is strong pre-clinical evidence that cannabidiol, the non-psychoactive ingredient, can limit the ability of brain immune cells to cause excessive inflammation, an exciting area of research that will reveal how particular strains of medical marihuana have the potential to not only alleviate symptoms of disease, but also reduce brain inflammation and disease progression. In addition, Dr. Ferreira brings his extensive training in microbiology and analytical chemistry to FAM’s quality assurance process. He will be responsible for overseeing all marihuana quality assurance testing provisioned under the MMPR, and applies his substantial training in laboratory management at the University of Toronto, and Toronto Western Research Institute (University Health Network) to oversee all good production practice
One of the more popular consumption options is to grind the cannabis bud and smoke it either in a device (like a pipe) or to use rolling papers to roll it into a marijuana cigarette (joint). If you wish to directly consume the cannabis bud but don’t wish to smoke, you can always use a Vaporizer – which is part of Beleave’s harm reduction program.